Colgate-Palmolive's growth is lackluster, with long-term sales and earnings barely keeping pace with inflation. Learn why CL ...

Santo Domingo.- Health authorities in the Dominican Republic have issued a warning about potential adverse reactions linked ...

Colgate-Palmolive Company (NYSE:CL) is included among the 10 Best Passive Income Stocks to Buy Now. The company has been ...

Colgate-Palmolive trades at $92.78 per share and has stayed right on track with the overall market, gaining 6% over the last six months. At the same time, the S&P 500 has returned 5%. Is now a good ...

Colgate-Palmolive boasts strong brands, growth in Pet Nutrition, and 62 years of dividend increases but faces valuation concerns. See more on CL stock here.

CL's strategic pricing, margin gains and productivity moves support steady EPS growth into 2025 despite cost pressures.

Colgate-Palmolive Company (NYSE:CL) is one of the Best Stagflation Stocks to Buy Now. On May 28, Piper Sandler reiterated its ...

Next week will see more than 150 companies from diverse sectors, including banking, pharmaceuticals, fintech, cement, and IT, ...

Nik Jhangiani, an industry veteran of Indian origin, has a career that spans over 30 years. He has held several senior ...

Business Insider's July 30 virtual event features executives talking about procurement innovation strategies. The panel ...

Colgate-Palmolive (NYSE:CL) is set to give its latest quarterly earnings report on Friday, 2025-04-25. Here's what investors need to know before the announcement. Analysts estimate that Colgate ...